Do Smokers' Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys

HH Yong; S Gravely; R Borland; C Gartner; KM Cummings; K East; S Tagliaferri; T Elton-Marshall; A Hyland; M Bansal-Travers; GT Fong

Journal article

Do Smokers' Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys

HH Yong, S Gravely, R Borland, C Gartner, KM Cummings, K East, S Tagliaferri, T Elton-Marshall, A Hyland, M Bansal-Travers, GT Fong

Nicotine and Tobacco Research | OXFORD UNIV PRESS | Published : 2022

DOI: 10.1093/ntr/ntac087

Download PDF

Abstract

Introduction: This study examined whether smokers' harm perceptions of nicotine replacement therapy (NRT) and nicotine vaping products (NVPs) relative to cigarettes predicted their subsequent use as smoking cessation aids during their last quit attempt (LQA). Aims and Methods: We analyzed data from 1,315 current daily smokers (10+ cigarettes per day) who were recruited at Wave 1 (2016), and who reported making a quit attempt by Wave 2 (2018) of the International Tobacco Control Four Country Smoking and Vaping Surveys in Australia, Canada, England, and the United States. We used multinomial logistic regression models to examine prospective associations between harm perceptions of (a) NRT and ..

View full abstract

University of Melbourne Researchers

Scott D Tagliaferri Author

Related Projects (3)

UNDERSTANDING THE IMPACTS OF VAPORISED NICOTINE PRODUCTS ON SMOKING IN AUSTRALIA

Vaporised nicotine products (e.g., e-cigarettes) are widely used in Australia, even though possession of the nicotine fluid without a permit..

Predicting and Understanding the use of nicotine products in a rapidly evolving nicotine marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study

The Centre of Research Excellence on Achieving the Tobacco Endgame (CREATE)

Grants

Awarded by Society for the Study of Addiction

Funding Acknowledgements

This study was supported by grants from the National Cancer Institute of the US (P01CA200512), the Canadian Institutes of Health Research (FDN-148477), and by the National Health and Medical Research Council of Australia (GNT1106451). Additional support to GTF was provided by a Senior Investigator Award from the Ontario Institute for Cancer Research and the Canadian Cancer Society O. Harold Warwick Prize and AH was supported by a Tobacco Centers of Regulatory Science US National Cancer Institute grant (U54CA238110). CG receives support from the National Health and Medical Research Council of Australia (GNT1198301). KE is the recipient of Fellowship funding from the UK Society for the Study of Addiction (SSA). The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit for publication.